Report cover image

Middle East Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Type (Small Molecule, Large Molecule), By Product, By Service, By Workflow (Clinical, Commercial), By Therapeutic Area, By End-use, B

Publisher Grand View Research
Published Sep 23, 2025
Length 120 Pages
SKU # GV20471110

Description

Middle East Healthcare Contract Development And Manufacturing Organization Market Summary

The Middle East healthcare contract development and manufacturing organization market size was estimated at USD 6.27 billion in 2024 and is projected to reach USD 11.91 billion by 2033, growing at a CAGR of 7.53% from 2025 to 2033. The market is experiencing significant growth driven by the increasing demand for biologics, generics, and complex formulations.

An increased emphasis on cost optimization within the pharmaceutical and biotechnology sectors further supports this trend. Rising healthcare expenditures across the region, along with an expanding patient base and government initiatives aimed at bolstering pharmaceutical manufacturing capacity, have accelerated outsourcing practices. There is a strong reliance on CDMOs as strategic partners, particularly due to rising demand for therapies targeting oncology, chronic diseases, and infectious diseases.

Technological advancements are enhancing efficiency, scalability, and quality within CDMO operations. Besides, innovations such as continuous manufacturing, single-use bioprocessing systems, and advanced analytical technologies are adopted to streamline production processes and decrease time to market. In addition, integrating AI, big data, and digital automation supports predictive analytics, quality assurance, and regulatory compliance reflecting a shift towards more innovative outsourcing solutions.

Moreover, investments are being made in infrastructure development, capacity expansion, and strategic partnerships to address the growing regional and international demand. Besides, collaboration between local and global players, including joint ventures with government agencies, is leading to establishing state-of-the-art manufacturing facilities. Venture capital investments and public-private partnerships actively contribute to expanding R&D capabilities, which are essential for developing specialized therapies, including biologics and biosimilars.

Furthermore, the regulatory landscape is evolving with global quality & safety standards. Besides, regional authorities enforce stringent guidelines to ensure compliance, adapt frameworks to encourage foreign investment, and expedite product approvals. Policies that support localization, intellectual property protection, and the establishment of GMP-certified facilities are being promoted, which makes Middle East-based CDMOs reliable outsourcing partners for multinational companies. Such factors are expected to drive the market.

Middle East Healthcare Contract Development And Manufacturing Organization Market Segmentation

This report forecasts revenue growth at and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East healthcare contract development and manufacturing organization market report based on type, product, service, workflow, therapeutic area, end-use, and region.
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Small Molecule
  • Branded
  • Generic
  • Large Molecule
  • Biologics
  • Biosimilar
  • Medical Device
  • Diagnostics
  • Therapeutics
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical
  • API
  • Traditional API
  • HP-API
  • Biologics
  • Others
  • Drug Product
  • Oral topical dose
  • Semi-solid dose
  • Liquid dose
  • Others
  • Medical Devices
  • Class I
  • Class II
  • Class III
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Contract Development
  • Pre-formulation & Formulation Development Service
  • Process Development & Optimization
  • Analytical Testing & Method Validation
  • Scale-up & Tech Transfer
  • Contract Manufacturing
  • API Manufacturing
  • Finished drug products Manufacturing
  • Medical Devices & Combination Products
  • Packaging and labelling
  • Regulatory Affairs
  • Others
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical
  • Commercial
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Infectious Diseases
  • Neurological Disorders
  • Cardiovascular Disease
  • Metabolic Disorders
  • Autoimmune Diseases
  • Respiratory Diseases
  • Ophthalmology
  • Gastrointestinal Disorders
  • Orthopedic Diseases
  • Dental Diseases
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • Saudi Arabia
  • UAE
  • Kuwait
  • Oman
  • Qatar
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Product
1.2.3. Service
1.2.4. Workflow
1.2.5. Therapeutic Area
1.2.6. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Botton-Up Approach
1.7.4. Multivariate Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Middle East Healthcare Contract Development and Manufacturing Organization Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL by SWOT Analysis
Chapter 4. Middle East Healthcare Contract Development and Manufacturing Organization Market: Type Estimates & Trend Analysis
4.1. Middle East Healthcare Contract Development and Manufacturing Organization Market, By Type: Segment Dashboard
4.2. Middle East Healthcare Contract Development and Manufacturing Organization Market, By Type: Movement Analysis
4.3. Middle East Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million)
4.4. Small Molecule
4.4.1. Small Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Branded
4.4.2.1. Branded Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Generic
4.4.3.1. Generic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Large Molecule
4.5.1. Large Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Biologics
4.5.2.1. Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Biosimilar
4.5.3.1. Biosimilar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Medical Device
4.6.1. Medical Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Diagnostics
4.6.2.1. Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Therapeutics
4.6.3.1. Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Healthcare Contract Development and Manufacturing Organization Market: Product Estimates & Trend Analysis
5.1. Middle East Healthcare Contract Development and Manufacturing Organization Market, By Product: Segment Dashboard
5.2. Middle East Healthcare Contract Development and Manufacturing Organization Market, By Product: Movement Analysis
5.3. Middle East Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Product, 2021 - 2033 (USD Million)
5.4. Pharmaceutical
5.4.1. Pharmaceutical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2. API
5.4.2.1. API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2.2. Traditional API
5.4.2.2.1. Traditional API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2.3. HP-API
5.4.2.3.1. HP-API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2.4. Biologics
5.4.2.4.1. Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2.5. Others
5.4.2.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3. Drug Product
5.4.3.1. Drug Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3.2. Oral Topical Dose
5.4.3.2.1. Oral Topical Dose Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3.3. Semi-Solid Dose
5.4.3.3.1. Semi-Solid Dose Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3.4. Liquid Dose
5.4.3.4.1. Liquid Dose Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3.5. Others
5.4.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Medical Devices
5.5.1. Medical Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.2. Class I
5.5.2.1. Class I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.3. Class II
5.5.3.1. Class II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.4. Class III
5.5.4.1. Class III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Healthcare Contract Development and Manufacturing Organization Market: Service Estimates & Trend Analysis
6.1. Middle East Healthcare Contract Development and Manufacturing Organization Market, By Service: Segment Dashboard
6.2. Middle East Healthcare Contract Development and Manufacturing Organization Market, By Service: Movement Analysis
6.3. Middle East Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
6.4. Contract Development
6.4.1. Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2. Pre-formulation & Formulation Development Service
6.4.2.1. Preformulation & Formulation Development Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Process Development & Optimization
6.4.3.1. Process Development & Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Analytical Testing & Method Validation
6.4.4.1. Analytical Testing & Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.5. Scale-up & Tech Transfer
6.4.5.1. Scale-up & Tech Transfer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Contract Manufacturing
6.5.1. Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. API Manufacturing
6.5.2.1. API Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Finished drug products Manufacturing
6.5.3.1. Finished drug products Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. Medical Devices & Combination Products
6.5.4.1. Medical Devices & Combination Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Packaging and Labelling
6.6.1. Packaging and Labelling Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Regulatory Affairs
6.7.1. Regulatory Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Others
6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East Healthcare Contract Development and Manufacturing Organization Market: Workflow Estimates & Trend Analysis
7.1. Middle East Healthcare Contract Development and Manufacturing Organization Market, By Workflow: Segment Dashboard
7.2. Middle East Healthcare Contract Development and Manufacturing Organization Market, By Workflow: Movement Analysis
7.3. Middle East Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Workflow, 2021 - 2033 (USD Million)
7.4. Clinical
7.4.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Commercial
7.5.1. Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Middle East Healthcare Contract Development and Manufacturing Organization Market: Therapeutic Area Estimates & Trend Analysis
8.1. Middle East Healthcare Contract Development and Manufacturing Organization Market, By Therapeutic Area: Segment Dashboard
8.2. Middle East Healthcare Contract Development and Manufacturing Organization Market, By Therapeutic Area: Movement Analysis
8.3. Middle East Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, By Therapeutic Area, 2021 - 2033 (USD Million)
8.4. Oncology
8.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Infectious Diseases
8.5.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Neurological Disorders
8.6.1. Neurological Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Cardiovascular Disease
8.7.1. Cardiovascular Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8. Metabolic Disorders
8.8.1. Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.9. Autoimmune Diseases
8.9.1. Autoimmune Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.10. Respiratory Diseases
8.10.1. Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.11. Ophthalmology
8.11.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.12. Gastrointestinal Disorders
8.12.1. Gastrointestinal Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.13. Orthopedic Diseases
8.13.1. Orthopedic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.14. Dental Diseases
8.14.1. Dental Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.15. Others
8.15.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Middle East Healthcare Contract Development and Manufacturing Organization Market: End Use Estimates & Trend Analysis
9.1. Middle East Healthcare Contract Development and Manufacturing Organization Market, By End Use: Segment Dashboard
9.2. Middle East Healthcare Contract Development and Manufacturing Organization Market, By End Use: Movement Analysis
9.3. Middle East Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
9.4. Pharmaceutical & Biotechnology Companies
9.4.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Medical Device Companies
9.5.1. Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. Others
9.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Middle East Healthcare Contract Development And Manufacturing Organization Market: Regional Estimates & Trend Analysis
10.1. Regional Market Dashboard
10.2. Regional Market Share Analysis, 2024 & 2033
10.3. Middle East
10.3.1. Middle East Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.2. Saudi Arabia
10.3.2.1. Key Country Dynamics
10.3.2.2. Competitive Scenario
10.3.2.3. Regulatory Framework
10.3.2.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.3. UAE
10.3.3.1. Key Country Dynamics
10.3.3.2. Competitive Scenario
10.3.3.3. Regulatory Framework
10.3.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.4. Kuwait
10.3.4.1. Key Country Dynamics
10.3.4.2. Competitive Scenario
10.3.4.3. Regulatory Framework
10.3.4.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.5. Oman
10.3.5.1. Key Country Dynamics
10.3.5.2. Competitive Scenario
10.3.5.3. Regulatory Framework
10.3.5.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.6. Qatar
10.3.6.1. Key Country Dynamics
10.3.6.2. Competitive Scenario
10.3.6.3. Regulatory Framework
10.3.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 11. Competitive Landscape
11.1. Key Participant Categorization
11.1.1. Market Leaders
11.1.2. Emerging Players
11.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
11.3. Company Profiles
11.3.1. Catalent Inc.
11.3.1.1. Company Overview
11.3.1.2. Financial Performance
11.3.1.3. Service Benchmarking
11.3.1.4. Strategic Initiatives
11.3.2. Recipharm AB
11.3.2.1. Company Overview
11.3.2.2. Financial Performance
11.3.2.3. Service Benchmarking
11.3.2.4. Strategic Initiatives
11.3.3. Thermo Fisher Scientific, Inc.
11.3.3.1. Company Overview
11.3.3.2. Financial Performance
11.3.3.3. Service Benchmarking
11.3.3.4. Strategic Initiatives
11.3.4. IQVIA Inc.
11.3.4.1. Company Overview
11.3.4.2. Financial Performance
11.3.4.3. Service Benchmarking
11.3.4.4. Strategic Initiatives
11.3.5. Syngene International Limited
11.3.5.1. Company Overview
11.3.5.2. Financial Performance
11.3.5.3. Service Benchmarking
11.3.5.4. Strategic Initiatives
11.3.6. Almac Group
11.3.6.1. Company Overview
11.3.6.2. Financial Performance
11.3.6.3. Service Benchmarking
11.3.6.4. Strategic Initiatives
11.3.7. Labcorp Drug Development
11.3.7.1. Company Overview
11.3.7.2. Financial Performance
11.3.7.3. Service Benchmarking
11.3.7.4. Strategic Initiatives
11.3.8. Lonza
11.3.8.1. Company Overview
11.3.8.2. Financial Performance
11.3.8.3. Service Benchmarking
11.3.8.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us